Akanda Corp. Common Shares (AKAN) Stock: Buy, Sell, or Hold?
AKAN - Akanda Corp. Common Shares
$1.15
0.00 (0.00%)
▲
5d:
-4.17%
30d:
-63.26%
90d:
-81.77%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Apr 29, 2026
0d
Get Alerted When AKAN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: AKAN shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: AKAN shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: AKAN is currently trading at $1.15, which is considered oversold relative to its 30-day fair value range of $1.41 to $2.91.
Technical Outlook: Technically, AKAN is in a strong downtrend. Immediate support is located at $1.00, while resistance sits at $1.83.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AKAN is in a strong downtrend. Immediate support is located at $1.00, while resistance sits at $1.83.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.41 -
$2.91
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: High volume confirmation
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.41 -
$2.91
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.00
Resistance Level
$1.83
Current Trend
Strong Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Revenue Growth (YoY)
21.9%
Share & Embed Analysis
Last updated: October 23, 2026 1:21 PM ET
Data refreshes hourly during market hours. Next update: 2:21 PM
Data refreshes hourly during market hours. Next update: 2:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AKAN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$207 | 56 HOLD |
|
ELAN
Elanco Animal Health |
STRONG BUY
16 analysts |
$31 | 47 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 62 BUY |
|
ALKS
Alkermes Plc |
STRONG BUY
19 analysts |
$56 | 38 SELL |
|
AMLX
Amylyx Pharmaceuticals I… |
STRONG BUY
12 analysts |
$43 | 54 HOLD |
